| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 16 |
| 1 | METHOTREXATE | 15 |
| 2 | METHOTREXATE SODIUM | 15 |
| 3 | NINTEDANIB | 14 |
| 4 | PREDNISONE | 13 |
| 5 | FUROSEMIDE | 11 |
| 6 | TACROLIMUS | 11 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 8 | TACROLIMUS OINTMENT 0.1% | 11 |
| 9 | IBUPROFEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.0769 |
| 1 | NYSTATIN TOPICAL POWDER | 1 | 0.0312 |
| 2 | BARICITINIB | 9 | 0.0029 |
| 3 | ADALIMUMAB-ATTO | 1 | 0.0006 |
| 4 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 5 | NINTEDANIB | 14 | 0.0004 |
| 6 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 8 | MYCOPHENILIC ACID | 4 | 0.0002 |
| 9 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 1 | Janus Kinase Inhibitor [EPC] | 13 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 10 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 18 | 0.0001 |
| 4 | Glycopeptide Antibacterial [EPC] | 3 | 0.0000 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 5 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 15 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 8 | Loop Diuretic [EPC] | 13 | 0.0000 |
| 9 | Polyene Antifungal [EPC] | 1 | 0.0000 |